Regioselective formation of new 3-S-alkylated-1,2,4-triazole-quinolones

References

• Kulkarni A, Török B. Microwave-assisted multicomponent domino cyclization–aromatization: an efficient approach for the synthesis of substituted quinolines. Green Chem. 2010;12:875–878.
   Web of Science ®Google Scholar
• Marella A, Tanwar OP, Saha R, et al. Quinoline: A versatile heterocyclic. Saudi Pharm J. 2013;21:1–12.
   PubMed Web of Science ®Google Scholar
• Musiol R, Serda M, Hensel-Bielowka S, et al. Quinoline-based antifungals. Curr Med Chem. 2010;17:1960–1973.
   PubMed Web of Science ®Google Scholar
• Guo H. Isatin derivatives and their antibacterial activities. Eur J Med Chem; 2019;164:678–688.
   PubMed Web of Science ®Google Scholar
• Furst AL, Francis MB. Impedance-based detection of bacteria. Chem Rev. 2018;119:700–726.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Pal M. Medicinal chemistry of quinolines as emerging anti-inflammatory agents: an overview. Curr Med Chem. 2013;20(35):4386–4410.
   PubMed Web of Science ®Google Scholar
• Zhang H, Ke L, Zhao H, et al. Synthesis and antitumor activity of fluoroquinolone C-3 s-triazole schiff-base carboxylic acid derivatives from pefloxacin (X). J China Pharm Univ. 2017;48:167–171.
   Web of Science ®Google Scholar
• Zhang S, Xu Z, Gao C, et al. Triazole derivatives and their anti-tubercular activity. Eur J Med Chem. 2017;138:501–513.
   PubMed Web of Science ®Google Scholar
• Dheer D, Singh V, Shankar R. Medicinal attributes of 1,2,3-triazoles: current developments. Bioorg Chem. 2017;71:30–54.
   PubMed Web of Science ®Google Scholar
• Gilandoust M, Harsha KB, Mohan CD, et al. Synthesis, characterization and cytotoxicity studies of 1,2,3-triazoles and 1,2,4-triazolo[1,5-a]pyrimidines in human breast cancer cells. Bioorg Med Chem Lett. 2018;28:2314–2319.
   PubMed Web of Science ®Google Scholar
• Fan YL, Ke X, Liu M. Coumarin–triazole hybrids and their biological activities. J Heterocycl Chem. 2018;55:791–802.
   Web of Science ®Google Scholar
• Gao C, Chang L, Xu Z, et al. Recent advances of tetrazole derivatives as potential anti-tubercular and anti-malarial agents. Eur J Med Chem. 2019;163:404–412.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang S, Ba Y, et al. 1, 2, 4-triazole-quinoline/quinolone hybrids as potential anti-bacterial agents. Eur J Med Chem. 2019;174:1–8.
   PubMed Web of Science ®Google Scholar
• Popiołek L, Kosikowska U, Mazur L, et al. Antimicrobial evaluation of some novel 1,2,4-triazole and 1,3,4-thiadiazole derivatives. Med Chem Res. 2013;22(7):3134–3147.
   PubMed Web of Science ®Google Scholar
• Xu JH, Fan YL, Zhou J. Quinolone–triazole hybrids and their biological activities. J Heterocycl Chem. 2018;55:1854–1862.
   Web of Science ®Google Scholar
• Wang Y, Damu GL, Lv JS, et al. Design, synthesis and evaluation of clinafloxacin triazole hybrids as a new type of antibacterial and antifungal agents. Bioorg Med Chem Lett. 2012;22:5363–5366.
   PubMed Web of Science ®Google Scholar
• Praveena KSS, Ramarao EVVS, Murthy NYS, et al. Design of new hybrid template by linking quinoline, triazole and dihydroquinoline pharmacophoric groups: A greener approach to novel polyazaheterocycles as cytotoxic agents. Bioorg Med Chem Lett. 2015;25(5):1057–1063.
   PubMed Web of Science ®Google Scholar
• Praveena KSS, Ramarao EVVS, Poornachandra Y, et al. Assembly of quinoline, triazole and Oxime ether in a single molecular entity: A greener and One-pot synthesis of novel Oximes as potential cytotoxic agents. Lett Drug Des Discovery. 2016;13(3):210–219.
   Web of Science ®Google Scholar
• Ikee Y, Hashimoto K, Nakashima M, et al. Synthesis and antibacterial activities of new quinolone derivatives utilizing 1-azabicyclo[1.1.0]butane. Bioorg Med Chem Lett. 2007;17:942–945.
   PubMed Web of Science ®Google Scholar
• Awolade P, Cele N, Kerru N, et al. Synthesis, antimicrobial evaluation, and in silico studies of quinoline—1H-1,2,3-triazole molecular hybrids. Molecular Diversity 2021 (in press). doi:10.1007/ s11030-020-10112-3.
   Google Scholar
• Hofny HA, Mohamed MFA, Gomaa HAM, et al. Design, synthesis, and antibacterial evaluation of new quinoline-1,3,4-oxadiazole and quinoline-1,2,4-triazole hybrids as potential inhibitors of DNA gyrase and topoisomerase IV. Bioorg Chem. 2021;12:104920.
   Google Scholar
• Hu G, Wang G, Duan N, et al. Design, synthesis and antitumor activities of fluoroquinolone C-3 heterocycles (IV): s-triazole schiff–Mannich bases derived from ofloxacin. Acta Pharm Sin B. 2012;2:312–317.
   Google Scholar
• Plech T, Kaproń B, Paneth A, et al. Search for factors affecting antibacterial activity and toxicity of 1,2,4-triazole-ciprofloxacin hybrids. Eur J Med Chem. 2015;97:94–103.
   PubMed Web of Science ®Google Scholar
• Cui SF, Ren Y, Zhang SL, et al. Synthesis and biological evaluation of a class of quinolone triazoles as potential antimicrobial agents and their interactions with calf thymus DNA. Bioorg Med Chem Lett. 2013;23:3267–3272.
   PubMed Web of Science ®Google Scholar
• Abdel-Aziz M, Abuo-Rahma GE-D, Beshr EAM, et al. New nitric oxide donating 1,2,4-triazole/oxime hybrids: synthesis, investigation of anti-inflammatory, ulceroginic liability and antiproliferative activities. Bioorg Med Chem. 2013;21(13):3839–3849.
   PubMed Web of Science ®Google Scholar
• Dincel ED, Ulusoy-Güzeldemirci N, Şatana D, et al. Design, synthesis, characterization and antimicrobial evaluation of some novel hydrazinecarbothioamide, 4-thiazolidinone and 1,2,4-triazole-3-thione derivatives. J Heterocycl Chem. 2021;58(1):195–205.
   Web of Science ®Google Scholar
• Šarkanj B, Molnar M, Čačić M, et al. 4-Methyl-7-hydroxycoumarin antifungal and antioxidant activity enhancement by substitution with thiosemicarbazide and thiazolidinone moieties. Food Chem. 2013;139(1-4):488–495.
   PubMed Web of Science ®Google Scholar
• Aly AA, Hassan AA, Mohamed NK, et al. Regioselective formation of 1,2,4-triazoles by reaction of amidrazones in the presence of azodicarboxylates. Mol Divers. 2019;23:195–203.
   PubMed Web of Science ®Google Scholar
• Mirzaei J, Amini M, Pirelahi H, et al. Convenient syntheses of 5-[(2-methyl-5-nitro-1H-imidazol-1-yl)methyl]-1,3,4- oxadiazole-2(3H)thione and N-substituted 2-amino-5-[(2-methyl-5-nitro-1H-imidazol-1-yl)methyl]-1,3,4-thiadiazoles. J Heterocycl Chem. 2008;45:921–928.
   Web of Science ®Google Scholar
• Buckle DR, Cantello BC, Smith H, et al. 4-Hydroxy-3-nitro-2-quinolones and related compounds as inhibitors of allergic reactions. J Med Chem. 1975;18:726–732.
   PubMed Web of Science ®Google Scholar
• Rao VS, Darbarwar M. One pot synthesis of 7-[1,2-dihydro-4-hydroxy-1-methyl/phenyl-2-Oxo-3-quinolinyl]-5,7-dihydro-5-methyl/phenyl-6H-[1]-benzopyrano[3,2-c]quinolin-6-ones. Synth Commun. 1988;18:2267–2272.
   Web of Science ®Google Scholar
• Chimichi S, Boccalini M, Cosimelli B. A new convenient route to 2-oxoethoxycoumarins: key intermediates in the synthesis of natural products. Tetrahedron. 2002;58:4851–4858.
   Web of Science ®Google Scholar
• Patel RV, Patel JK, Kumari P, et al. Synthesis of novel quinolone and coumarin based 1,3,4-thiadiazolyl and 1,3,4-oxadiazolyl N-Mannich bases as potential antimicrobials. Lett Org Chem. 2012;9:478–486.
   Web of Science ®Google Scholar
• Panda SS, Malik R, Chand M, et al. Synthesis and antimicrobial activity of some new 4-triazolylmethoxy-2H-chromen-2-one derivatives. Med Chem Res. 2012;21:3750–3756.
   Web of Science ®Google Scholar
• Sheldrick GM. SHELXT - Integrated space-group and crystal-structure determination. Acta Crystallogr. 2015;A71:3–8.
   Google Scholar
• Sheldrick GM. Crystal structure refinement with SHELXL. Acta Crystallogr. 2015;C71:3–8.
   Google Scholar